URGENT: This Altcoin Opportunity Won’t Wait – Act Now

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

VTYX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 18.18%

Insider Buying (Last 12 Months): $1,262,415.36

Insider Selling (Last 12 Months): $69,531.06

Ventyx Biosciences Insider Trading History Chart

Ventyx Biosciences Share Price & Price History

^$2.38

▲ +0.05 (2.15%)

As of 12/27/2024 06:30 PM ET

Days: 30 | 90 | 365

Last time you’ll see this priced at $1.00

From StocksToTrade | Ad

When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore!

Click here to review Tim’s special Holiday offer before it’s too late.

Ventyx Biosciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/23/2024	Sheila Gujrathi	Director	Buy	130,000	$2.31	$300,300.00	130,000
12/19/2024	John Nuss	Insider	Sell	13,161	$2.26	$29,743.86	485,701
11/25/2024	Raju Mohan	CEO	Buy	261,752	$2.01	$526,121.52	2,175,028
11/22/2024	Raju Mohan	CEO	Buy	238,248	$1.83	$435,993.84	1,913,276
4/2/2024	Christopher W Krueger	Insider	Sell	1,651	$5.40	$8,915.40	284,999
4/2/2024	Martin Auster	CFO	Sell	1,405	$5.40	$7,587.00	24,303
4/2/2024	Raju Mohan	CEO	Sell	4,312	$5.40	$23,284.80	1,578,250
12/20/2023	John Nuss	Insider	Sell	17,628	$2.12	$37,371.36	262,118
12/20/2023	Raju Mohan	CEO	Sell	58,860	$2.12	$124,783.20	1,570,719
10/9/2023	Nsv Partners Iii Lp	Major Shareholder	Sell	49,152	$30.03	$1,476,034.56	8,439,635
10/5/2023	Raju Mohan	CEO	Sell	30,000	$29.11	$873,300.00	1,512,911
10/3/2023	Christopher W Krueger	Insider	Sell	15,000	$29.98	$449,700.00	276,548
9/18/2023	Somu Subramaniam	Director	Sell	56,665	$37.81	$2,142,503.65	8,488,787
8/31/2023	William J Sandborn	Insider	Sell	11,900	$33.64	$400,316.00	48,389
8/8/2023	William J Sandborn	Insider	Sell	3,494	$32.86	$114,812.84	24,194
8/7/2023	Raju Mohan	CEO	Sell	30,000	$33.52	$1,005,600.00	1,512,911
8/3/2023	John Nuss	Insider	Sell	10,000	$35.60	$356,000.00	244,815
7/31/2023	Somu Subramaniam	Director	Sell	10,803	$37.59	$406,084.77	8,545,452
7/31/2023	William J Sandborn	Insider	Sell	11,900	$37.16	$442,204.00	48,389
7/28/2023	Somu Subramaniam	Director	Sell	611	$37.53	$22,930.83	8,556,255
7/25/2023	Martin Auster	CFO	Sell	28,000	$35.54	$995,120.00	47,649
7/12/2023	Somu Subramaniam	Director	Sell	3,275	$37.62	$123,205.50	8,556,866
7/11/2023	Nsv Partners Iii Lp	Major Shareholder	Sell	28,646	$37.54	$1,075,370.84	8,560,141
7/7/2023	Somu Subramaniam	Director	Sell	100,000	$35.23	$3,523,000.00	9,552,965
7/5/2023	Raju Mohan	CEO	Sell	30,000	$38.37	$1,151,100.00	1,512,911
7/3/2023	John Nuss	Insider	Sell	20,000	$39.58	$791,600.00	244,815
7/3/2023	Nsv Partners Iii Lp	Major Shareholder	Sell	134,080	$39.00	$5,229,120.00	9,652,965
6/23/2023	William J Sandborn	Insider	Sell	10,790	$32.70	$352,833.00	48,389
6/15/2023	William J Sandborn	Insider	Sell	3,487	$34.15	$119,081.05	31,175
6/14/2023	Somu Subramaniam	Director	Sell	50,000	$35.08	$1,754,000.00	9,787,045
6/7/2023	Nsv Partners Iii Lp	Major Shareholder	Sell	35,872	$35.66	$1,279,195.52	9,837,045
6/6/2023	Martin Auster	CFO	Sell	28,000	$34.64	$969,920.00	47,649
6/6/2023	Somu Subramaniam	Director	Sell	4,128	$35.00	$144,480.00	9,872,917
6/5/2023	Christopher W Krueger	Insider	Sell	15,000	$34.36	$515,400.00	276,548
6/5/2023	Raju Mohan	CEO	Sell	30,000	$34.36	$1,030,800.00	1,513,126
5/31/2023	William J Sandborn	Insider	Sell	10,629	$34.26	$364,149.54	48,389
5/15/2023	William J Sandborn	Insider	Sell	3,487	$36.47	$127,170.89	34,662
5/5/2023	Raju Mohan	CEO	Sell	30,000	$39.28	$1,178,400.00	1,543,126
5/3/2023	John Nuss	Insider	Sell	10,000	$38.64	$386,400.00	244,815
4/28/2023	William J Sandborn	Insider	Sell	10,790	$36.96	$398,798.40	48,389
4/25/2023	Martin Auster	CFO	Sell	28,000	$38.04	$1,065,120.00	47,649
4/25/2023	Somu Subramaniam	Director	Sell	793	$38.88	$30,831.84	9,877,045
4/24/2023	Nsv Partners Iii Lp	Major Shareholder	Sell	90,565	$38.64	$3,499,431.60	9,877,838
4/21/2023	Nsv Partners Iii Lp	Major Shareholder	Sell	8,642	$37.51	$324,161.42	9,968,403
4/17/2023	Martin Auster	CFO	Sell	7,000	$33.00	$231,000.00	47,649
4/13/2023	Nsv Partners Iii Lp	Major Shareholder	Sell	71,446	$30.31	$2,165,528.26	9,977,045
4/12/2023	Somu Subramaniam	Director	Sell	28,554	$30.01	$856,905.54	10,048,491
4/10/2023	Raju Mohan	CEO	Sell	9,255	$29.01	$268,487.55	1,573,126
4/5/2023	Raju Mohan	CEO	Sell	13,230	$29.81	$394,386.30	1,589,896
4/4/2023	Martin Auster	CFO	Sell	21,000	$30.76	$645,960.00	47,649
4/3/2023	Christopher W Krueger	Insider	Sell	15,000	$32.88	$493,200.00	276,117
3/30/2023	Sheila Gujrathi	Director	Sell	100,000	$33.73	$3,373,000.00
1/23/2023	William Richard White	Director	Sell	33,353	$35.10	$1,170,690.30
12/22/2022	John Nuss	Insider	Sell	13,812	$31.61	$436,597.32	244,815
12/22/2022	Raju Mohan	CEO	Sell	55,354	$31.61	$1,749,739.94	1,603,126
12/16/2022	Somu Subramaniam	Director	Sell	146,825	$32.94	$4,836,415.50	12,974,786
12/15/2022	Nsv Partners Iii Lp	Major Shareholder	Sell	153,175	$33.61	$5,148,211.75	13,121,611
12/13/2022	Christopher W Krueger	Insider	Sell	30,000	$34.46	$1,033,800.00	272,692
12/5/2022	John Nuss	Insider	Sell	50,000	$28.23	$1,411,500.00	258,696
12/5/2022	Raju Mohan	CEO	Sell	23,003	$28.44	$654,205.32	1,541,811
12/2/2022	Christopher W Krueger	Insider	Sell	50,000	$29.01	$1,450,500.00	302,692
12/2/2022	Martin Auster	CFO	Sell	97,647	$29.01	$2,832,739.47	47,649
12/2/2022	Raju Mohan	CEO	Sell	276,997	$29.01	$8,035,682.97	1,564,814
12/1/2022	Somu Subramaniam	Director	Sell	129,317	$29.01	$3,751,486.17	16,616,048
11/30/2022	Nsv Partners Iii Lp	Major Shareholder	Sell	143,228	$29.01	$4,155,044.28	16,745,365
11/7/2022	Somu Subramaniam	Director	Sell	3,935	$29.08	$114,429.80	16,888,593

Last time you’ll see this priced at $1.00

From StocksToTrade | Ad

When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore!

Click here to review Tim’s special Holiday offer before it’s too late.

SEC Filings (Institutional Ownership Changes) for Ventyx Biosciences (NASDAQ:VTYX)

97.88% of Ventyx Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Ventyx Biosciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/26/2024	JPMorgan Chase & Co.	1,007,519	$2.20M	0.0%	+2.0%	1.425%
11/19/2024	Barclays PLC	80,295	$0.18M	0.0%	+273.1%	0.114%
11/16/2024	Geode Capital Management LLC	1,391,702	$3.03M	0.0%	+5.9%	1.968%
11/15/2024	Barclays PLC	80,295	$0.18M	0.0%	+273.1%	0.114%
11/15/2024	XTX Topco Ltd	112,713	$0.25M	0.0%	N/A	0.159%
11/15/2024	Jane Street Group LLC	42,272	$92K	0.0%	-71.0%	0.060%
11/15/2024	State Street Corp	1,187,650	$2.59M	0.0%	+0.8%	1.680%
11/15/2024	Redmile Group LLC	2,107,215	$4.59M	0.3%	-2.6%	2.980%
11/15/2024	Point72 DIFC Ltd	34,589	$75K	0.0%	-48.1%	0.049%
11/15/2024	Ikarian Capital LLC	192,647	$0.42M	0.1%	-56.5%	0.272%
11/15/2024	Jacobs Levy Equity Management Inc.	568,479	$1.24M	0.0%	+19.5%	0.804%
11/15/2024	Point72 Asia Singapore Pte. Ltd.	12,096	$26K	0.0%	-52.2%	0.017%
11/14/2024	Vestal Point Capital LP	1,725,000	$3.76M	0.3%	+31.2%	2.440%
11/14/2024	Sio Capital Management LLC	1,971,948	$4.30M	1.7%	+153.2%	2.789%
11/14/2024	Walleye Capital LLC	390,102	$0.85M	0.0%	-23.6%	0.552%
11/14/2024	MetLife Investment Management LLC	15,188	$33K	0.0%	-54.5%	0.021%
11/12/2024	Charles Schwab Investment Management Inc.	485,101	$1.06M	0.0%	+3.8%	0.686%
11/9/2024	Intech Investment Management LLC	19,161	$42K	0.0%	N/A	0.027%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	462,170	$1.01M	0.0%	+10.2%	0.654%
11/7/2024	LMR Partners LLP	100,000	$0.22M	0.0%	N/A	0.142%
10/28/2024	Palumbo Wealth Management LLC	12,140	$26K	0.0%	N/A	0.017%
10/25/2024	China Universal Asset Management Co. Ltd.	13,592	$30K	0.0%	+64.1%	0.019%
10/3/2024	SG Americas Securities LLC	34,670	$76K	0.0%	+149.8%	0.049%
9/16/2024	Point72 DIFC Ltd	66,615	$0.15M	0.0%	N/A	0.094%
9/16/2024	Cubist Systematic Strategies LLC	149,500	$0.35M	0.0%	+165.8%	0.212%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	25,303	$58K	0.0%	N/A	0.036%
8/15/2024	The Manufacturers Life Insurance Company	24,349	$56K	0.0%	+41.1%	0.035%
8/15/2024	Dark Forest Capital Management LP	38,126	$88K	0.0%	N/A	0.054%
8/15/2024	Deerfield Management Company L.P. Series C	5,829,570	$13.47M	0.2%	+64.6%	8.269%
8/15/2024	AQR Capital Management LLC	56,551	$0.13M	0.0%	N/A	0.080%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	25,303	$58K	0.0%	N/A	0.036%
8/14/2024	Squarepoint Ops LLC	76,539	$0.18M	0.0%	+101.3%	0.109%
8/14/2024	Cubist Systematic Strategies LLC	149,500	$0.35M	0.0%	+165.8%	0.212%
8/14/2024	Point72 DIFC Ltd	66,615	$0.15M	0.0%	N/A	0.094%
8/8/2024	American Century Companies Inc.	25,883	$60K	0.0%	N/A	0.037%
8/6/2024	Acadian Asset Management LLC	263,565	$0.61M	0.0%	N/A	0.374%
8/1/2024	Rhumbline Advisers	90,331	$0.21M	0.0%	+38.0%	0.128%
7/26/2024	Bank of New York Mellon Corp	230,593	$0.53M	0.0%	+58.4%	0.327%
7/12/2024	SG Americas Securities LLC	13,878	$32K	0.0%	N/A	0.020%
7/10/2024	Simplicity Wealth LLC	22,361	$52K	0.0%	-24.0%	0.032%
5/29/2024	Opaleye Management Inc.	1,285,000	$7.07M	1.5%	+12.7%	1.823%
5/24/2024	Farallon Capital Management LLC	3,170,000	$17.44M	0.1%	N/A	4.496%
5/17/2024	Ikarian Capital LLC	507,647	$2.79M	0.3%	+8,483.8%	0.720%
5/16/2024	California State Teachers Retirement System	4,706	$26K	0.0%	-90.0%	0.007%
5/16/2024	Redmile Group LLC	2,164,126	$11.90M	0.4%	+944.4%	3.070%
5/15/2024	First Light Asset Management LLC	624,842	$3.44M	0.3%	N/A	0.886%
5/15/2024	Price T Rowe Associates Inc. MD	48,027	$0.27M	0.0%	-76.4%	0.068%
5/14/2024	Qiming U.S. Ventures Management LLC	412,225	$2.27M	2.5%	-39.9%	0.585%
5/10/2024	Vanguard Group Inc.	3,705,472	$20.38M	0.0%	-1.0%	5.256%
5/8/2024	Bleakley Financial Group LLC	29,451	$0.16M	0.0%	-9.7%	0.042%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	13,169	$72K	0.0%	N/A	0.019%
4/30/2024	Norden Group LLC	10,685	$59K	0.0%	N/A	0.015%
4/29/2024	China Universal Asset Management Co. Ltd.	11,385	$63K	0.0%	+66.6%	0.016%
4/24/2024	Simplicity Wealth LLC	29,405	$0.16M	0.0%	N/A	0.042%
4/19/2024	Norden Group LLC	10,685	$59K	0.0%	N/A	0.015%
2/15/2024	Opaleye Management Inc.	1,140,000	$2.82M	0.8%	N/A	1.931%
2/13/2024	Tower Research Capital LLC TRC	19,927	$49K	0.0%	+1,424.6%	0.034%
2/13/2024	Capital International Investors	2,354,149	$5.82M	0.0%	-13.7%	3.987%
2/9/2024	Aigen Investment Management LP	26,238	$65K	0.0%	N/A	0.044%
2/9/2024	Dynamic Technology Lab Private Ltd	130,749	$0.32M	0.0%	N/A	0.221%
2/7/2024	Jump Financial LLC	29,060	$72K	0.0%	N/A	0.049%
1/31/2024	Federated Hermes Inc.	20,407	$50K	0.0%	N/A	0.035%
1/29/2024	Simplicity Solutions LLC	32,628	$81K	0.0%	N/A	0.055%
1/25/2024	Bleakley Financial Group LLC	32,628	$81K	0.0%	N/A	0.055%
1/12/2024	SG Americas Securities LLC	37,261	$92K	0.0%	+61.4%	0.063%
12/18/2023	Vanguard Group Inc.	2,662,671	$92.48M	0.0%	+11.7%	4.509%
12/7/2023	Hudson Bay Capital Management LP	248,515	$8.63M	0.1%	+160.2%	0.421%
12/6/2023	Citigroup Inc.	10,143	$0.35M	0.0%	-77.8%	0.017%
12/1/2023	Wellington Management Group LLP	1,342,977	$46.64M	0.0%	-0.5%	2.274%
11/15/2023	Redmile Group LLC	929,900	$32.30M	1.5%	-1.1%	1.575%
11/15/2023	Sectoral Asset Management Inc.	88,000	$3.06M	0.6%	N/A	0.149%
11/15/2023	Acuta Capital Partners LLC	205,377	$7.13M	4.8%	+39.4%	0.348%
11/15/2023	Adage Capital Partners GP L.L.C.	987,970	$34.31M	0.1%	+962.7%	1.673%
11/14/2023	venBio Partners LLC	758,800	$26.35M	7.5%	+78.9%	1.292%
11/14/2023	Fred Alger Management LLC	46,644	$1.62M	0.0%	-22.7%	0.079%
11/14/2023	Avidity Partners Management LP	354,900	$12.33M	0.5%	-48.8%	0.604%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	63,944	$2.22M	0.0%	+139.5%	0.109%
11/13/2023	FMR LLC	8,677,529	$301.37M	0.0%	+1.5%	14.780%
11/13/2023	Rafferty Asset Management LLC	6,017	$0.21M	0.0%	N/A	0.010%
11/13/2023	Lord Abbett & CO. LLC	1,729,464	$60.06M	0.2%	-25.4%	2.946%
11/9/2023	Loomis Sayles & Co. L P	1,257,973	$43.69M	0.1%	+26.0%	2.143%
11/9/2023	Qiming U.S. Ventures Management LLC	686,370	$23.84M	31.6%	-8.0%	1.169%
11/9/2023	Deutsche Bank AG	101,908	$3.54M	0.0%	-12.0%	0.174%
11/8/2023	Charles Schwab Investment Management Inc.	363,385	$12.62M	0.0%	+42.3%	0.619%
11/8/2023	Swiss National Bank	90,200	$3.13M	0.0%	+9.5%	0.154%
11/8/2023	JSF Financial LLC	6,000	$0.21M	0.1%	N/A	0.010%
11/7/2023	Quantbot Technologies LP	10,971	$0.38M	0.0%	-42.6%	0.019%
11/7/2023	Barclays PLC	228,220	$7.93M	0.0%	+872.9%	0.389%
11/7/2023	Arizona State Retirement System	11,671	$0.41M	0.0%	+9.8%	0.020%
11/6/2023	Victory Capital Management Inc.	259,634	$9.02M	0.0%	-23.3%	0.442%
10/31/2023	Teacher Retirement System of Texas	11,642	$0.40M	0.0%	+13.4%	0.020%
10/31/2023	China Universal Asset Management Co. Ltd.	1,506	$52K	0.0%	+96.3%	0.003%
10/27/2023	TIAA Trust National Association	41,875	$1.45M	0.0%	N/A	0.071%
10/27/2023	TD Asset Management Inc	155,408	$5.40M	0.0%	+44.9%	0.265%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	7,855	$0.27M	0.0%	+36.0%	0.013%
10/25/2023	Brown Advisory Inc.	42,481	$1.48M	0.0%	+35.3%	0.072%
10/24/2023	Bank of New York Mellon Corp	164,152	$5.70M	0.0%	+10.4%	0.280%
10/20/2023	Avestar Capital LLC	11,412	$0.40M	0.1%	+10.0%	0.019%
10/19/2023	Peregrine Capital Management LLC	94,565	$3.28M	0.1%	-5.9%	0.161%
10/13/2023	SG Americas Securities LLC	23,084	$0.80M	0.0%	+18.3%	0.039%

Data available starting January 2016

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.

Today's Range

Now: $2.38

$2.32

$2.50

50 Day Range

MA: $2.29

$1.72

$3.12

52 Week Range

Now: $2.38

$1.67

$11.48

Volume

2,889,604 shs

Average Volume

2,041,856 shs

Market Capitalization

$168.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.48

Who are the company insiders with the largest holdings of Ventyx Biosciences?: Ventyx Biosciences' top insider investors include:
Somu Subramaniam (Director)
Nsv Partners Iii Lp (Major Shareholder)
Raju Mohan (CEO)
John Nuss (Insider)
Christopher W Krueger (Insider)
Sheila Gujrathi (Director)
William J Sandborn (Insider)
Martin Auster (CFO)
William Richard White (Director)
Learn More about top insider investors at Ventyx Biosciences.
Who are the major institutional investors of Ventyx Biosciences?: Ventyx Biosciences' top institutional investors include:
Redmile Group LLC — 2.98%
Sio Capital Management LLC — 2.79%
Vestal Point Capital LP — 2.44%
Geode Capital Management LLC — 1.97%
State Street Corp — 1.68%
JPMorgan Chase & Co. — 1.42%
Learn More about top institutional investors of Ventyx Biosciences stock.
Which institutional investors are selling Ventyx Biosciences stock?: Within the last quarter, VTYX stock was sold by these institutional investors:
Ikarian Capital LLC
Walleye Capital LLC
Jane Street Group LLC
Redmile Group LLC
Point72 DIFC Ltd
MetLife Investment Management LLC
Point72 Asia Singapore Pte. Ltd.
Within the last year, company insiders that have sold Ventyx Biosciences company stock include:
Somu Subramaniam (Director)
Nsv Partners Iii Lp (Major Shareholder)
Raju Mohan (CEO)
John Nuss (Insider)
Learn More investors selling Ventyx Biosciences stock.
Which institutional investors are buying Ventyx Biosciences stock?: During the last quarter, VTYX stock was acquired by institutional investors including:
Sio Capital Management LLC
Vestal Point Capital LP
XTX Topco Ltd
LMR Partners LLP
Jacobs Levy Equity Management Inc.
Geode Capital Management LLC
Barclays PLC
Barclays PLC
Within the previous year, these company insiders have bought Ventyx Biosciences stock:
Somu Subramaniam (Director)
Nsv Partners Iii Lp (Major Shareholder)
Learn More investors buying Ventyx Biosciences stock.